Indy
Provider 
Founded 2021
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Venture-backed

Indy is Inductive Bio AI chemistry assistant guiding chemists through design, synthesis, and assay decisions.
Indy embeds frontier chemistry models inside the medicinal chemistry workflow, proposing molecules, routes, and experiments ranked by predicted dose and developability.
Chemists steer each cycle while Indy retrieves consortium evidence and prior program outcomes, compressing design-make-test-analyze loops for biopharma teams.
| Attribute | Indy | Computational Molecular Discovery Platform, LiveDesign | Makya | |
|---|---|---|---|---|
| Provider | ||||
| Founded | 2021 | 1990 | 2016 | |
| Sells To | Enterprise | Enterprise | — | |
| Pricing Model | Recurring, Software | Recurring, Software, Transactional | — | |
| Ownership | Venture-backed | Public | — |
Provider 
Founded 2021
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Venture-backed
Provider 
Founded 1990
Sells To Enterprise
Pricing Model Recurring, Software, Transactional
Ownership Public
Founded 2016
Sells To —
Pricing Model —
Ownership —



Machine learning platform for drug discovery and development.


Tamarind Bio Assay Portal routes AI designs to experimental affinity validation.


Automated cloud laboratory that runs a broad menu of biology and chemistry experiments on behalf of researchers.


Foundation-model platform for designing sequence-based medicines including siRNA, ASO, mRNA, and peptides.


Weave AutoIND is an AI platform for automating IND and regulatory submission drafting for biotech and pharma.


AI-native platform that designs, runs, and improves plate-based scientific experiments autonomously.


Biomedical AI platform that grounds biopharma R&D decisions in validated biology.


Medicinal chemistry and drug discovery consulting service of ChemTract, led by owner James M. Balkovec.


Chai-1 is a multi-modal foundation model for molecular structure prediction across proteins, small molecules, DNA, and RNA.


QikProp predicts ADME and pharmacokinetic properties of drug candidates from three dimensional structure.
Agentic AI platform for RNA drug discovery covering ASO and siRNA design through lead optimization.

Machine learning platform for drug discovery and development.

Tamarind Bio Assay Portal routes AI designs to experimental affinity validation.

Automated cloud laboratory that runs a broad menu of biology and chemistry experiments on behalf of researchers.

LLM-powered AI agent for lipid nanoparticle research and formulation optimization.

Foundation-model platform for designing sequence-based medicines including siRNA, ASO, mRNA, and peptides.

Weave AutoIND is an AI platform for automating IND and regulatory submission drafting for biotech and pharma.

AI-native platform that designs, runs, and improves plate-based scientific experiments autonomously.

Biomedical AI platform that grounds biopharma R&D decisions in validated biology.

Medicinal chemistry and drug discovery consulting service of ChemTract, led by owner James M. Balkovec.

Chai-1 is a multi-modal foundation model for molecular structure prediction across proteins, small molecules, DNA, and RNA.

QikProp predicts ADME and pharmacokinetic properties of drug candidates from three dimensional structure.
